Changes

Jump to: navigation, search

Vortioxetine-agomelatine

124 bytes removed, 13:14, 4 August 2023
no edit summary
{{Drugswitch
| from = Vortioxetine vortioxetine
| to = agomelatine
| stop =
| stop = {{stopVortioxetineStopvortioxetine}}| start = {{StartAgomelatine|15}}* '''Day 9:''' start administration of agomelatine in a dosage of 25 mg/day. |info = * '''Day 23:''' if necessary, increase dosage of agomelatine to 50 mg/day.References <ref name="agoswitchvortiswitch"> {{Pubmed|2019618724570588 |McAllister-Williams RH Katona et al. The use of New generation multi-modal antidepressants in clinical practice: focus on agomelatine. Hum Psychopharmacolvortioxetine for major depressive disorder. 2010 Mar 12014 2014 Feb 19;25(2)10:95349-10254}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref> <ref name="Summary of Product Characteristics"> [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002717/WC500159449.pdf Summary of Product Characteristics Vortioxetine]</ref>
|info = * see references <ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>
}}

Navigation menu